3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
3
Phase 4
3
Phase 2
3
Phase 3
1
Status
Completed
2
Terminated
1
Sponsor Class
OTHER
2
INDUSTRY
1
Study Type
Interventional
3
Sponsor
Conditions
Vomiting
8
Nausea
5
Neoplasms
3
Lymphoma
3
Breast Neoplasms
3
Leukemia
2
Uterine Neoplasms
1
Thyroid Neoplasms
1
Sezary Syndrome
1
Pruritus
1
Post-Dural Puncture Headache
1
Ovarian Neoplasms
1
Hematologic Neoplasms
1
Interventions
Dexamethasone
8
Oxycodone
6
Epoetin Alfa
5
Propofol
4
Palonosetron
4
Meropenem
4
Zoledronic Acid
3
Vancomycin
3
Sevoflurane
3
Ondansetron
3
Naloxone
3
Everolimus
3
Ciprofloxacin
3
Cholecalciferol
3
Ceftazidime
3
Cefepime
3
Calcium Dobesilate
3
Bevacizumab
3
Aspirin
3
Aprepitant
3
peginterferon alfa-2a
2
edoxaban
2
apixaban
2
apatinib
2
Vitamin B 12
2
Vincristine
2
Tobacco Use Cessation Devices
2
Teicoplanin
2
Tablets
2
Surgical Procedures, Operative
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase 4
×
Neoplasms
×
Aprepitant
×
Clear all
NCT00588835
2020-11-30
ACE
Radboud University Medical Center
Phase 4
Terminated
20 enrolled
NCT01636947
2018-09-25
KMEC
Merck Sharp & Dohme LLC
Phase 4
Completed
494 enrolled
14 charts
NCT02532634
2018-05-11
RAPA
Kangdong Sacred Heart Hospital
Phase 4
Completed
292 enrolled